
Oncologist

No OPD information available
Colorectal Cancer
Gastrointestinal Stromal Tumor
Lung Metastases
Brain Tumor
Breast Cancer
Cholecystitis
COVID-19
Gallbladder Disease
Gallbladder Removal
Hepatitis B
Lung Cancer
Melanoma
Metastatic Brain Tumor
Pancreatic Cancer
Pancreatic Ductal Adenocarcinoma
Penectomy
Pneumonia
Renal Cell Carcinoma (RCC)
Severe Acute Respiratory Syndrome (SARS)
Stomach Cancer
Venous Thromboembolism (VTE)
Desmond Yip is a male healthcare provider who helps people with various health issues like colorectal cancer, lung cancer, brain tumors, and more. He also treats conditions like pneumonia, hepatitis B, and COVID-19. Desmond Yip is skilled in caring for patients with different types of cancer and other diseases.
Desmond Yip communicates with patients in a caring and understanding way, which helps them feel comfortable and trust him. Patients appreciate his clear explanations and the time he takes to listen to their concerns. Desmond Yip stays updated with the latest medical knowledge and research to provide the best care possible to his patients.
Desmond Yip works well with other medical professionals, collaborating to ensure patients receive comprehensive care. He values teamwork and respects his colleagues, promoting a positive work environment. Desmond Yip's dedication to teamwork and patient care has earned him the trust and respect of his peers.
Desmond Yip's work has had a positive impact on many patients' lives. His research on neoadjuvant chemotherapy for pancreatic cancer has contributed to improving treatment outcomes. He has also conducted clinical trials to explore new treatment options for patients with challenging conditions like intrahepatic cholangiocarcinoma.
Through his commitment to patient care, continuous learning, and collaboration with colleagues, Desmond Yip has made a significant difference in the lives of those he treats. His compassionate approach and dedication to staying informed about the latest advancements in medicine have earned him a reputation as a trusted and skilled healthcare provider.
Enrollment Status: Completed
Published: April 12, 2023
Intervention Type: Device, Drug
Study Drug: Cisplatin-Gemcitabine
Study Phase: Phase 2/Phase 3
